Consider a pallet that arrives on site. Scanners read 48 cases, but the aggregation data sent with the shipment lists 50. Although the product is physically present and correctly labeled, its electronic record no longer matches what is on the dock, so the pallet is held until the gap is explained. This gap is a serialization exception.
Serialization exception management is the work of investigating and resolving discrepancies between a pharmaceutical product’s physical status and its electronic record, such as aggregation mismatches, duplicate serial numbers or missing transaction data, between a product’s physical status and its electronic record.
Pharmaceutical manufacturers have invested heavily in serialization infrastructure, generating vast amounts of data about products and their movement across the supply chain. But when a discrepancy occurs, finding the information needed to investigate and resolve it can be far from straightforward.
Detecting an exception is only the first step. Resolving it means answering four questions:
- What caused the discrepancy?
- Which serialized products are affected?
- Could product movement or release be disrupted?
- Who is responsible for taking action?
The longer teams spend piecing together information and coordinating responses, the greater the risk of operational disruption. Resolving issues efficiently depends on giving everyone involved a clear view of what happened and a way to work toward resolution. Contact an expert to learn more.
What causes delays in serialization exception investigations?
Established serialization infrastructure is designed to meet regulatory requirements and support product traceability, including recording where every unit has been and exchanging that record with trading partners and regulators under requirements such as the US Drug Supply Chain Security Act (DSCSA). They are not typically designed to help people investigate why records disagree. That gap shows up in four ways:
- Fragmented data makes it difficult to establish what happened
Pharmaceutical supply chains span multiple sites and vendors, including contract manufacturing organizations (CMOs) and third-party logistics providers (3PLs), each with their own systems and processes. When an exception occurs, the information needed to investigate it may be distributed across these environments.Teams must piece together records from different sources to understand a product’s journey and establish where the discrepancy originated. Without connected infrastructure, it can be challenging to determine whether an issue affects an individual serialized unit, a case, a pallet or a wider shipment. - Specialist dependency creates investigation bottlenecks
Accessing serialization information often requires specialist technical knowledge. As a result, quality and supply chain teams may depend on serialization specialists or helpdesk teams to locate and retrieve relevant records.Even straightforward questions can require specialist intervention before quality or supply chain teams get the information they need. As investigations progress, this dependency can delay access to the information needed to assess the issue and decide what happens next. - Manual reconciliation adds complexity and risk
When systems cannot easily share information, people are left to bridge the gaps. Spreadsheets and emails become the tools for reconciling serialization records across disconnected environments.Teams may need to compare serial numbers and event histories manually, relying on screenshots or separate email threads to clarify discrepancies with internal functions or external partners.Offline and disconnected processes introduce opportunities for errors and duplicated effort. They also make it harder to maintain a consistent understanding of an issue as new information emerges. - Unclear ownership slows responses
Resolving serialization exceptions can involve multiple functions and organizations. One team may investigate the original discrepancy, while another must verify records or determine the operational implications.Without defined responsibilities and shared workflows, accountability can become unclear as the issue moves between teams. Time is lost coordinating responses and confirming whether the necessary actions have been completed. In a multi-party exception, the CMO, product owner and 3PL can each assume someone else is leading.
How do investigation delays affect pharmaceutical supply chain operations?
A disconnected investigation can quickly become an operational problem. When records are fragmented and investigation workflows are disconnected, teams can struggle to establish where affected products are located or whether they can continue moving through the supply chain.
Without that visibility, quality and supply chain leaders may be unable to assess how urgently an exception needs to be addressed. Decisions about product movement or release can be delayed while teams work to establish the facts.
The longer uncertainty persists, the greater the potential for disruption. Delayed decisions can affect delivery schedules and create additional rework across manufacturing and distribution operations.
Even when the underlying discrepancy is relatively straightforward to resolve, the time spent locating information and coordinating the response can create avoidable operational friction. Contact an expert to learn more.
How can serialization exceptions be resolved faster?
Faster issue resolution requires connected information and a clear way for teams to work together. Manufacturers need a solution that brings serialization data together across sites and trading partners, allowing teams to access relevant product and event histories without manually reconstructing records from disconnected systems. Investigators need the affected serial numbers, their aggregation relationships and the full event history in one place, linked across sites and trading partners through standards such as Electronic Product Code Information Services (EPCIS), rather than rebuilt by hand from separate systems.
Crucially, this solution must also support collaborative issue management, giving internal teams and external partners a shared environment to investigate issues and coordinate their resolution. Rather than relying on separate emails and spreadsheets, teams need governed workflows that establish clear ownership, support corrective actions and maintain visibility through resolution.
With connected data and collaborative workflows in place, teams can move from identifying an issue to resolving it faster. This reduces reliance on manual reconciliation and specialist support while helping quality and supply chain teams coordinate responses that minimize disruption to product movement.
Make serialization data work harder for your operations
Serialization data already provides pharmaceutical manufacturers with a valuable foundation for traceability. Connecting that information with the people and processes responsible for acting on it offers an opportunity to reduce operational friction and accelerate exception resolution.
In our latest eBook, we explore how manufacturers can unlock greater operational value from their existing serialization infrastructure and support more connected, efficient supply chain operations.
Discover how connected serialization data can reduce manual investigation and help you coordinate a faster response.